Word

IOMX

Status

Registered

Status Code

700

Status Date

Tuesday, January 5, 2021

Serial Number

87802718

Registration Number

6236118

Registration Date

Tuesday, January 5, 2021

Mark Type

4000

Filing Date

Monday, February 19, 2018

Published for Opposition

Tuesday, October 20, 2020

Trademark Owner History

IOmx Therapeutics AG - Original Registrant

Classifications

5 Pharmaceuticals, medical and veterinary preparations, pharmaceutical preparations and formulations, and medicated health preparations, all of the aforesaid goods for use in the treatment or prevention of human and animal diseases, disorders and conditions, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, pulmonary, musculoskeletal, lymphatic or gastrointestinal diseases, disorders and conditions, and for use in the treatment or prevention of complications associated with such diseases, disorders and conditions; Pharmaceuticals, medical and veterinary preparations, pharmaceutical preparations and formulations, and medicated health preparations, all of the aforesaid goods for use in the treatment or prevention of human and animal diseases, disorders and conditions, namely, bone sensory, viral, urinary, renal, metabolic or central nervous system diseases, disorders and conditions, and for use in the treatment or prevention of complications associated with such diseases, disorders and conditions; Pharmaceuticals, medical and veterinary preparations, pharmaceutical preparations and formulations, and medicated health preparations, all of the aforesaid goods for use in the treatment or prevention of human and animal diseases, disorders and conditions, namely, infectious, auto-immune or immune-related, cell-proliferative or oncologic diseases, disorders and conditions, cancers, tumours and metastases, and for use in the treatment or prevention of complications associated with such diseases, disorders and conditions; Diagnostic preparations and biomarker reagents for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, pulmonary, musculoskeletal, lymphatic or gastrointestinal diseases, disorders and conditions, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions; Diagnostic preparations and biomarker reagents for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, bone sensory, viral, urinary, renal, metabolic or central nervous system diseases, disorders and conditions, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions; Diagnostic preparations and biomarker reagents for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, infectious, auto-immune or immune-related, cell-proliferative or oncologic diseases, disorders and conditions, cancers, tumours and metastases, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions

10 Diagnostic apparatus for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, pulmonary, musculoskeletal, lymphatic or gastrointestinal diseases, disorders and conditions, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions, specifically, sample-analysis devices and related data-analysis software sold as a unit, nucleic acid-analysis or protein-analysis diagnosis apparatus, and diagnostic apparatus utilizing a diagnostic or prognosis algorithm and related algorithm software sold as a unit; Diagnostic apparatus for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, bone sensory, viral, urinary, renal, metabolic or central nervous system diseases disorders and conditions, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions, specifically, sample-analysis devices and related data-analysis software sold as a unit, nucleic acid-analysis or protein-analysis diagnosis apparatus, and diagnostic apparatus utilizing a diagnostic or prognosis algorithm and related algorithm software sold as a unit; Diagnostic apparatus for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, infectious, auto-immune or immune-related, cell-proliferative or oncologic diseases, disorders and conditions, cancers, tumours and metastases, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions, specifically, sample-analysis devices and related data-analysis software sold as a unit, nucleic acid-analysis or protein-analysis diagnosis apparatus, and diagnostic apparatus utilizing a diagnostic or prognosis algorithm and related algorithm software sold as a unit

42 Scientific services, namely, scientific research, analysis and testing in the fields of biology, chemistry or medicine, as well as in the fields of immunology, oncology, molecular biology, cellular biology, biochemistry and medicinal chemistry; Scientific services, namely, scientific research, analysis and testing in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations and biomarker reagents, and diagnostic apparatus; Design and development of computer software for database management, cloud-storage of data, data-management, data-query, data-analysis and data-presentation, for the query, analysis and presentation of the sequence or structure of molecules, or for predicting or providing a medical diagnosis or prognosis, as well as for controlling and managing patient medical information, with any of the aforementioned services for use in the fields of biology, chemistry or medicine, as well as for use in the fields of immunology, oncology, molecular biology, cellular biology, biochemistry and medicinal chemistry; Design and development of computer software for database management, cloud-storage of data, data-management, data-query, data-analysis and data-presentation, as well as for the query, analysis and presentation of the sequence or structure of molecules, or for predicting or providing a medical diagnosis or prognosis, with any of the aforementioned services for use in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations and biomarker reagents, and diagnostic apparatus

Trademark Events

Feb 8, 2024

Teas Change Of Correspondence Received

Feb 8, 2024

Teas Change Of Domestic Representatives Address

Feb 8, 2024

Teas Withdrawal As Domestic Representative Received

Feb 8, 2024

Attorney/Dom.Rep.Revoked And/Or Appointed

Feb 8, 2024

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Feb 8, 2024

Applicant/Correspondence Changes (Non-Responsive) Entered

Feb 8, 2024

Teas Change Of Owner Address Received

Mar 6, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Mar 6, 2023

Teas Change Of Correspondence Received

Mar 6, 2023

Teas Change Of Domestic Representatives Address

Mar 6, 2023

Teas Withdrawal Of Attorney Received-Firm Retains

Mar 6, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Mar 6, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Mar 6, 2023

Teas Change Of Owner Address Received

Oct 8, 2021

Teas Change Of Correspondence Received

Oct 8, 2021

Teas Withdrawal As Domestic Representative Received

Oct 8, 2021

Teas Withdrawal Of Attorney Received-Firm Retains

Oct 8, 2021

Attorney/Dom.Rep.Revoked And/Or Appointed

Oct 8, 2021

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jan 5, 2021

Registered-Principal Register

Oct 20, 2020

Official Gazette Publication Confirmation E-Mailed

Oct 20, 2020

Published For Opposition

Sep 30, 2020

Notification Of Notice Of Publication E-Mailed

Sep 15, 2020

Electronic Record Review Complete

Sep 11, 2020

On Hold - Electronic Record Review Required

Sep 10, 2020

Approved For Pub - Principal Register

Aug 25, 2020

Teas/Email Correspondence Entered

Aug 24, 2020

Correspondence Received In Law Office

Aug 24, 2020

Teas Request For Reconsideration Received

Jul 9, 2020

Notification Of Final Refusal Emailed

Jul 9, 2020

Final Refusal E-Mailed

Jul 9, 2020

Final Refusal Written

Jun 24, 2020

Suspension Checked - To Attorney For Action

Dec 18, 2019

Report Completed Suspension Check Case Still Suspended

Jun 18, 2019

Report Completed Suspension Check Case Still Suspended

Dec 12, 2018

Notification Of Letter Of Suspension E-Mailed

Dec 12, 2018

Letter Of Suspension E-Mailed

Dec 12, 2018

Suspension Letter Written

Dec 10, 2018

Teas/Email Correspondence Entered

Dec 10, 2018

Correspondence Received In Law Office

Dec 3, 2018

Teas Response To Office Action Received

Jun 4, 2018

Notification Of Non-Final Action E-Mailed

Jun 4, 2018

Non-Final Action E-Mailed

Jun 4, 2018

Non-Final Action Written

Jun 4, 2018

Assigned To Examiner

Apr 3, 2018

Preliminary/Voluntary Amendment - Entered

Mar 30, 2018

Assigned To Lie

Mar 16, 2018

Teas Voluntary Amendment Received

Feb 26, 2018

New Application Office Supplied Data Entered

Feb 22, 2018

New Application Entered